Published in Circulation on March 01, 1985
Determinants of left ventricular function one year after cardiac transplantation. Br Heart J (1988) 0.98
Diastolic function after cardiac and heart-lung transplantation. Br Heart J (1989) 0.81
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
Hemodynamic Characteristics Including Pulmonary Hypertension at Rest and During Exercise Before and After Heart Transplantation. J Am Heart Assoc (2015) 0.75
The conceptual framework of the International Tobacco Control (ITC) Policy Evaluation Project. Tob Control (2006) 10.62
A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med (1996) 8.02
Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
The biosynthesis and functional role of cardiolipin. Prog Lipid Res (2000) 3.60
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Ultrasound-assisted cannulation of the internal jugular vein. A prospective comparison to the external landmark-guided technique. Circulation (1993) 3.31
Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation (1996) 3.14
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (2000) 3.13
A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J Virol (1995) 3.11
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Synthesis and characterization of phosphorescent cyclometalated iridium complexes. Inorg Chem (2001) 2.94
Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver. Surg Gynecol Obstet (1985) 2.88
Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Highly phosphorescent bis-cyclometalated iridium complexes: synthesis, photophysical characterization, and use in organic light emitting diodes. J Am Chem Soc (2001) 2.61
Ill-health retirement: national rates and updated guidance for occupational physicians. Occup Med (Lond) (2005) 2.53
Lessons learned in pediatric heart transplantation. Ann Thorac Surg (1989) 2.46
The reliability and predictive validity of the Heaviness of Smoking Index and its two components: findings from the International Tobacco Control Four Country study. Nicotine Tob Res (2010) 2.34
Randomized comparison of a strategy of predischarge coronary angiography versus exercise testing in low-risk patients in a chest pain unit: in-hospital and long-term outcomes. J Am Coll Cardiol (2001) 2.27
Absence of cardiolipin in the crd1 null mutant results in decreased mitochondrial membrane potential and reduced mitochondrial function. J Biol Chem (2000) 2.26
Cardiac transplantation with cyclosporin A and prednisone. Ann Surg (1982) 2.21
A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J (1997) 2.16
Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med (1999) 2.15
Hydroxylated quantum dots as luminescent probes for in situ hybridization. J Am Chem Soc (2001) 2.12
Regulatory mutations of inositol biosynthesis in yeast: isolation of inositol-excreting mutants. Genetics (1982) 2.10
Managing chronic atrial fibrillation: a Markov decision analysis comparing warfarin, quinidine, and low-dose amiodarone. Ann Intern Med (1994) 2.10
Alternative approach to multivessel coronary disease with integrated coronary revascularization. J Thorac Cardiovasc Surg (1999) 2.08
Influence of treatment with diet alone on oral glucose-tolerance test and plasma sugar and insulin levels in patients with maturity-onset diabetes mellitus. Lancet (1975) 2.06
Blood usage in lung transplantation. Transfusion (1998) 2.06
Anatomical variations of internal jugular vein location: impact on central venous access. Crit Care Med (1991) 2.06
Techniques for combined procurement of hearts and kidneys with satisfactory early function of renal allografts. Surg Gynecol Obstet (1983) 2.03
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03
Augmentation mammaplasty associated with a severe systemic illness. Ann Plast Surg (1979) 1.96
Absent right superior vena cava with persistent left superior vena cava: implications and management. Am J Cardiol (1980) 1.94
Solid tumors after heart transplantation: lethality of lung cancer. Ann Thorac Surg (1995) 1.92
A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol (2000) 1.89
Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. J Infect Dis (1985) 1.88
Minimally invasive coronary artery bypass grafting. Ann Thorac Surg (1996) 1.81
Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase. Circulation (2000) 1.76
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med (1987) 1.75
Macrophage accumulation associated with rat cardiac allograft rejection detected by magnetic resonance imaging with ultrasmall superparamagnetic iron oxide particles. Circulation (2001) 1.74
Randomized trial of thrombolysis versus heparin in unstable angina. Circulation (1992) 1.74
Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation (1987) 1.71
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science (1992) 1.71
BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem (1999) 1.71
Characterization of a yeast regulatory mutant constitutive for synthesis of inositol-1-phosphate synthase. Mol Gen Genet (1982) 1.70
Queuing for coronary angiography during severe supply-demand mismatch in a US public hospital: analysis of a waiting list registry. JAMA (1999) 1.67
Early Function of Heart, Liver, and Kidney Allografts Following Combined Procurement. Transplant Proc (1984) 1.66
Isolation and characterization of a near-haploid human cell line. Exp Cell Res (1999) 1.66
CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retroviruses (1993) 1.66
Interactions between bronchoalveolar lymphocytes and macrophages in heart-lung transplant recipients. Hum Immunol (1985) 1.65
Spinal cord tumors in children: long-term results of combined surgical and radiation treatment. J Neurosurg (1994) 1.65
Traumatic aortic rupture: diagnosis and management. Ann Thorac Surg (1998) 1.64
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother (2005) 1.63
Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant (1999) 1.63
Hyperuricemia and gout among heart transplant recipients receiving cyclosporine. Am J Med (1992) 1.58
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J Virol (2001) 1.58
Cusp Replacement and Coronary Artery Perfusion in Open Operations on the Aortic Valve. Ann Surg (1960) 1.58
Long-term survivors of pediatric heart transplantation: a multicenter report of sixty-eight children who have survived longer than five years. J Pediatr (1997) 1.57
Anomalous origin of the left coronary artery from the pulmonary artery. A new method of surgical repair. Circulation (1974) 1.57
Principles of multiple organ procurement from cadaver donors. Ann Surg (1983) 1.56
A distinctive clade B HIV type 1 is heterosexually transmitted in Trinidad and Tobago. Proc Natl Acad Sci U S A (2000) 1.55
Health metrics improve childhood immunisation coverage in a rural population of Andhra Pradesh. Indian J Public Health (2009) 1.55
Yeast mutant defective in phosphatidylcholine synthesis. J Bacteriol (1983) 1.55
Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant (1992) 1.54
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg (1995) 1.54
Impact of human immunodeficiency virus type 1 gp41 amino acid substitutions selected during enfuvirtide treatment on gp41 binding and antiviral potency of enfuvirtide in vitro. J Virol (2005) 1.53
Optimal perioperative immunosuppression in cardiac transplantation using rabbit antithymocyte globulin. Transplantation (1990) 1.52
Autonomic mechanisms in hemodynamic responses to isometric exercise. J Clin Invest (1974) 1.51